Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency

What is the definition of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency?

Long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency is a rare condition that prevents the body from converting certain fats to energy, particularly during periods without food (fasting).

What are the causes of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency?

Variants (also known as mutations) in the HADHA gene cause LCHAD deficiency. The HADHA gene provides instructions for making part of an enzyme complex called mitochondrial trifunctional protein. This enzyme complex functions in mitochondria, the energy-producing centers within cells. As the name suggests, mitochondrial trifunctional protein contains three enzymes that each perform a different function. This enzyme complex is required to break down (metabolize) a group of fats called long-chain fatty acids. Long-chain fatty acids are found in foods such as milk and certain oils. These fatty acids are stored in the body's fat tissues. Fatty acids are a major source of energy for the heart and muscles. During periods of fasting, fatty acids are also an important energy source for the liver and other tissues.

How prevalent is Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency?

The incidence of LCHAD deficiency is unknown. One estimate, based on a Finnish population, indicates that 1 in 62,000 pregnancies is affected by this disorder. In the United States, the incidence is probably much lower.

Is Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency an inherited disorder?

This condition is inherited in an autosomal recessive pattern, which means both copies of the gene in each cell have variants. The parents of an individual with an autosomal recessive condition each carry one copy of the altered gene, but they typically do not show signs and symptoms of the condition.

Who are the top Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Local Doctors?
Distinguished in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
Distinguished in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency

Fa CV Consultants PC

127 Pine St Ste 1, 
Montclair, NJ 
Languages Spoken:
English

Fadi A Elatat is a Cardiologist in Montclair, New Jersey. Dr. A Elatat is rated as a Distinguished provider by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. His top areas of expertise are Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency, Arterial Embolism, Lemierre Syndrome, Mondor Disease, and Hernia Surgery.

Advanced in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
Medical Genetics | Pediatrics
Advanced in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
Medical Genetics | Pediatrics

St. Christopher's Pediatric Associates Genetics - E. Erie Avenue

160 E Erie Ave, 
Philadelphia, PA 
Languages Spoken:
English

. Dr. Arnold is rated as an Advanced provider by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. Her top areas of expertise are Phenylketonuria (PKU), Mitochondrial Trifunctional Protein Deficiency, Krabbe Disease, and Inborn Amino Acid Metabolism Disorder.

 
 
 
 
Learn about our expert tiers
Learn More
Jose' A. Sahel
Advanced in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
Ophthalmology
Advanced in Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency
Ophthalmology

UPMC Vision Institute

1622 Locust Street, Floor 2, 
Pittsburgh, PA 
Languages Spoken:
English, French
Accepting New Patients
Offers Telehealth

Jose' Sahel is an Ophthalmologist in Pittsburgh, Pennsylvania. Dr. Sahel is rated as an Advanced provider by MediFind in the treatment of Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency. His top areas of expertise are Retinopathy Pigmentary Mental Retardation, Cone-Rod Dystrophy, X-Linked Congenital Stationary Night Blindness, Retinitis Pigmentosa, and Vitrectomy. Dr. Sahel is currently accepting new patients.

What are the latest Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
Who are the sources who wrote this article ?

Published Date: January 20, 2023
Published By: National Institutes of Health